Shirley P. Huang

Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation

David M. Mannino, Michael Bogart, Guillaume Germain et al. · International Journal of COPD · 2022 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109

Kevin W. Garey, Jinhee Jo, Anne J Gonzales-Luna et al. · JAMA Network Open · 2023 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States

Christopher F. Bell, Shirley P. Huang, Anissa Cyhaniuk et al. · Lupus · 2022 · 17 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +17

Validation of a Health-Related Quality of Life Questionnaire in Patients With Recurrent <i>Clostridioides difficile</i> Infection in ECOSPOR III, a Phase 3 Randomized Trial

Brittany Lapin, Kevin W. Garey, Henry Wu et al. · Clinical Infectious Diseases · 2022 · 11 citations

Life Sciences, Infectious Diseases, Microbiology +16

Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study

Shirley P. Huang, Amy Guisinger, Carlyne M. Averell et al. · Rheumatology and Therapy · 2023 · 10 citations · Full text

Pharmacy, Nephrology, Pharmacoeconomics +17